By Justin Lygrisse (Director of R&D for the Nasal Spray business unit at Kindeva)2025-11-10T09:00:12
Advances in formulation science and device technology are transforming nasal drug delivery, enhancing absorption, stability and patient adherence. This article examines the innovations driving its growth and highlights future applications ranging from systemic treatments to nose-to-brain therapies and vaccines.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-02-23T14:02:18
Sponsored by bit.bio
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud